在生物醫(yī)學(xué)和生物技術(shù)領(lǐng)域，實(shí)驗(yàn)結(jié)果的穩(wěn)健性往往取決于工具的選擇。提到轉(zhuǎn)染試劑PEI，許多科研人員都會將其視為一種經(jīng)過長期實(shí)踐驗(yàn)證的成熟工具。

一、客觀數(shù)據(jù)：PEI轉(zhuǎn)染試劑的普遍應(yīng)用

Polysciences旗下Kyfora Bio的PEI轉(zhuǎn)染試劑（如PEI MAX）在科研界擁有龐大的用戶基礎(chǔ)。據(jù)不全部統(tǒng)計(jì)，全球已有數(shù)萬家實(shí)驗(yàn)室和眾多生物技術(shù)公司選擇使用這款PEI，相關(guān)應(yīng)用案例可見于數(shù)萬篇科研文獻(xiàn)中。從基礎(chǔ)研究到技術(shù)轉(zhuǎn)化，從基因編輯到病毒載體包裝，PEI的應(yīng)用場景十分多元。

二、解析PEI轉(zhuǎn)染試劑的科研優(yōu)勢

•性能穩(wěn)定：針對HEK293、CHO等常用細(xì)胞系，PEI轉(zhuǎn)染試劑通常能提供較為穩(wěn)定的轉(zhuǎn)染效率，并保持較低的細(xì)胞毒性，有助于實(shí)驗(yàn)數(shù)據(jù)的重復(fù)性。

•經(jīng)濟(jì)實(shí)用：相比部分脂質(zhì)體試劑，PEI在成本和性能之間取得了較好的平衡，適合實(shí)驗(yàn)室進(jìn)行規(guī)?；瘧?yīng)用。

•適用性廣：無論是CRISPR基因編輯還是AAV病毒生產(chǎn)，PEI都能滿足多樣化的實(shí)驗(yàn)需求，簡化實(shí)驗(yàn)流程。

三、選擇Kyfora by Polysciences PEI的科研考量

當(dāng)實(shí)驗(yàn)方案中采用PEI轉(zhuǎn)染試劑時(shí)，這種成熟的技術(shù)路徑通常更容易被同行理解和接受。Kyfora by Polysciences的PEI作為一種科研工具，其價(jià)值體現(xiàn)在：

• 助力成果發(fā)表：使用經(jīng)過豐富文獻(xiàn)驗(yàn)證的方法，有助于減少審稿人對實(shí)驗(yàn)技術(shù)路線的疑慮。

• 提升實(shí)驗(yàn)效率：穩(wěn)定的性能可以減少實(shí)驗(yàn)條件的反復(fù)摸索，讓科研人員更專注于科學(xué)問題的研究。

• 優(yōu)化資源配置：在保證實(shí)驗(yàn)效果的前提下，有助于實(shí)驗(yàn)室更合理地規(guī)劃科研經(jīng)費(fèi)。

四、Polysciences中國渠道與曼博生物的無憂售后

在生物醫(yī)學(xué)和生物技術(shù)領(lǐng)域，選擇可靠的供應(yīng)商與選擇可靠的試劑同等重要。Polysciences及其旗下品牌Kyfora Bio在中國的直售提供商——上海曼博生物醫(yī)藥有限公司，正是連接技術(shù)與國內(nèi)科研用戶的重要橋梁。

選擇Polysciences PEI，就是選擇“一站式"服務(wù)保障

作為Polysciences在中國市場的長期戰(zhàn)略合作伙伴，上海曼博生物建立了售前、售中、售后服務(wù)體系以及重組的國內(nèi)庫存。其技術(shù)團(tuán)隊(duì)具備豐富的產(chǎn)品應(yīng)用經(jīng)驗(yàn)，能夠針對不同細(xì)胞系（如HEK293、CHO等）的轉(zhuǎn)染難題，提供專業(yè)的技術(shù)支持與優(yōu)化方案，協(xié)助客戶解決實(shí)驗(yàn)過程中遇到的實(shí)際問題。

五、結(jié)語

在科研工作中，選擇可靠的工具十分關(guān)鍵。Kyfora by Polysciences的PEI轉(zhuǎn)染試劑，憑借其在全球科研界積累的多數(shù)應(yīng)用案例，為研究人員提供了一種成熟、穩(wěn)定且經(jīng)濟(jì)實(shí)用的技術(shù)選擇。無論您是初入實(shí)驗(yàn)室的新手，還是經(jīng)驗(yàn)豐富的研究者，這款PEI都能為您的科研工作提供有力的支持。

選擇上海曼博生物，意味著您購買的每一支PEI轉(zhuǎn)染試劑都享有原廠質(zhì)保與直售商的專業(yè)服務(wù)，實(shí)現(xiàn)“正品無憂、售后無憂"，讓您能更專注于科研本身，解除后顧之憂。

參考文獻(xiàn)

1.Huang Y, Hartley O, Afione SA, et al. AAV2 production with optimized N/P ratio and PEI-mediated transfection results in low toxicity and high titer for in vitro and in vivo applications. Journal of Virological Methods. 2013;193(2):270-277. doi:10.1016/j.jviromet.2013.06.008. 

2.Sigma-Aldrich. Development of a Novel Cell Culture Medium for AAV Production With Multiple HEK293 Lineages and Process Optimization. Technical Document. 2026. 

3.Lu M, Lee Z, Hu WS. Multi-omics kinetic analysis of recombinant adeno-associated virus production by plasmid transfection of HEK293 cells. Biotechnology Progress. 2024;40(2):e3428. doi:10.1002/btpr.3428. 

4.  Comprehensive transient transfection process optimization to improve AAV productivity by tackling PEI induced ROS and thus reducing cytotoxicity. ACS Synthetic Biology Conference Proceedings. 2023. 

5.Lock M, Chen J, et al. Rapid, Simple and Versatile Manufacturing of Recombinant Adeno-Associated Virus Vectors at Scale. ResearchGate. 2007. 

6.Hsu SH, Hwang KC, Lin YC, et al. Biocompatibility and efficacy of oligomaltose-grafted poly(ethylene imine)s (OM-PEIs) for in vivo gene delivery. Journal of Biomedical Materials Research Part A. 2014;102(1):209-218. doi:10.1002/jbm.a.34720.

7.Stuible M, Gervais C, Lord-Dufour S, et al. Rapid, high-yield production of full-length SARS-CoV-2 spike ectodomain by transient gene expression in CHO cells. Journal of Biotechnology. 2021;328:21-27. doi:10.1016/j.jbiotec.2020.12.005. 

8.Bausch D, Luginbühl P, Ruppen I, et al. Cost-Effective Protein Production in CHO Cells Following Polyethylenimine-Mediated Gene Delivery Showcased by the Production and Crystallization of Antibody Fabs. Antibodies. 2023;12(3):51. doi:10.3390/antib12030051. 

10.Li R, Secombes CJ, Zou J. Transient transfection of CHO cells using linear polyethylenimine is a simple and effective means of producing rainbow trout recombinant IFN-γ protein. Cytotechnology. 2015;67(6):987-993. doi:10.1007/s10616-014-9737-9. 

11.Zhou J, Yan GG, Cluckey D, et al. Exploring Parametric and Mechanistic Differences between Expi293F™ and ExpiCHO-S™ Cells for Transient Antibody Production Optimization. Antibodies. 2023;12(3):53. doi:10.3390/antib12030053.

12.Ozturk S, Zhou J, Kamen A. Influence of glutamine on transient and stable recombinant protein production in CHO and HEK-293 cells. Biotechnology and Bioengineering. 2009;102(5):1434-1443. doi:10.1002/bit.22932.

13.Durocher Y, Perret S, Kamen A. Transfection of HEK293-EBNA1 Cells in Suspension with Linear PEI for Production of Recombinant Proteins. Nucleic Acids Research. 2002;30(2):E9. doi:10.1093/nar/30.2.e9.

14.Fichter C, Aggarwal A, Wong AKH, et al. Modular Lentiviral Vectors for Highly Efficient Transgene Expression in Resting Immune Cells. Viruses. 2021;13(6):1170. doi:10.3390/v13061170. 

15.Cattle MA, Aguado LC, Sze S, et al. An enhanced Eco1 retron editor enables precision genome engineering in human cells without double-strand breaks. Nucleic Acids Research. 2025;53(14):gkaf716. doi:10.1093/nar/gkaf716. 

16.Kuroda H, Kutner RH, Bazan NG, Reiser J. Optimization of lentiviral vector production using polyethylenimine-mediated transfection. Journal of Virological Methods. 2009;157(2):113-121. doi:10.1016/j.jviromet.2008.11.021. 

17.Dhekne H, Pfeffer SR. Small scale Lentivirus Production and Infection. protocols.io. 2022. doi:10.17504/protocols.io.bp2l61z2zvqe/v1. 

18.Yang S, Zhou X, Li R, et al. Optimized PEI-based Transfection Method for Transient Transfection and Lentiviral Production. Current Protocols in Chemical Biology. 2017;9(4):e56. doi:10.1002/cpch.56. 

19.A feasibility study of different commercially available serum-free mediums to enhance lentivirus and adeno-associated virus production in HEK 293 suspension cells. Biotechnology Journal. 2023;18(3):202200450. doi:10.1002/biot.202200450. 

20.McCarron A, Donnelley M, McIntyre C, et al. Lentiviral vector production using single-use bioreactors. Cytiva Life Sciences. 2021.